KRTL BioTech

Activist Rubric nominates two directors at Xperi. Here’s how the firm may help enhance shareholder value

Activist Rubric nominates two directors at Xperi. Here’s how the firm may help enhance shareholder value

There are opportunities for cost cutting at Xperi, and fresh blood on the board might be what it takes to build value.